Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 2/20 | 0.56 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.56 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | CA12 | O43570 | 6/20 | 0.45 |
| ▸ | CA4 | P22748 | 6/20 | 0.45 |
| ▸ | CA9 | Q16790 | 6/20 | 0.45 |
| ▸ | CA1 | P00915 | 2/20 | 0.45 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | CA7 | P43166 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | ERN1 | O75460 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2024267 | 0.81 | MAOB (0.45) | CA12CA4CA9CA1GSTP1 | |
| SCHEMBL4638260 | 0.81 | GSTP1 (0.45) | CA12CA4CA9CA1GSTP1 | |
| SCHEMBL9634543 | 0.78 | ALDH1A1 (0.63) | TYRTRIM24TRIM33MAPTCA12 | |
| SCHEMBL1004413 | 0.78 | TYR (0.66) | TYRTRIM24TRIM33POLBMAPT | |
| SCHEMBL29708063 | 0.78 | TYR (0.66) | TYRTRIM24TRIM33POLBMAPT | |
| SCHEMBL28486841 | 0.78 | TYR (0.61) | TYRTRIM24TRIM33POLBMAPT | |
| SCHEMBL19640150 | 0.77 | HPGD (0.41) | TYRTRIM24TRIM33GSTP1ALDH1A1 | |
| SCHEMBL14149542 | 0.77 | MAOB (0.45) | CA12CA4CA9CA1GSTP1 | |
| SCHEMBL15080749 | 0.77 | KDM4E (0.52) | CA12CA4CA9CA1GSTP1 | |
| SCHEMBL17848287 | 0.77 | GSTP1 (0.42) | POLBMAPTCA12CA4CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121293265-A | Cholesterol-salicylaldehyde conjugate, preparation method, application and N based on cholesterol-salicylaldehyde conjugate2H4And pH fluorescence analysis and gel response method | 西安交通大学 | 2026-01-09 | — | — | CN | disclosed |
| US-11129909-B2 | Conjugate and block copolymer containing fluorescent chromophore and preparation method therefor and use thereof | UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA (CN) | 2021-09-28 | — | — | US | disclosed |
| US-20200155707-A1 | CONJUGATE AND BLOCK COPOLYMER CONTAINING FLUORESCENT CHROMOPHORE AND PREPARATION METHOD THEREFOR AND USE THEREOF | UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA (CN) | 2020-05-21 | — | — | US | disclosed |
| US-5104881-A | 2-ARYLIMIDAZOPYRIDINES | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1992-04-14 | — | — | US | disclosed |
| US-4654344-A | ALSO AFFECT BLOOD PRESSURE AND MYOCARDIAL CONTRACTIONS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1987-03-31 | — | — | US | disclosed |
| US-4616090-A | 2-arylimidazopyridines intermediates | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1986-10-07 | — | — | US | disclosed |
| EP-0072926-B1 | 2-ARYLIMIDAZOPYRIDINES | MERCK PATENT GmbH (DE) | 1986-09-24 | — | — | EP | disclosed |
| US-4575505-A | Pharmaceutical compositions containing 2-aryltetraazaindenes for treating ulcers or cardiac insufficiency or blood pressure abnormalities | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1986-03-11 | — | — | US | disclosed |
| US-4477454-A | INDOTROPIC AGENTS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1984-10-16 | — | — | US | disclosed |
| EP-0093951-A2 | 2-Aryl-tetraazaindenes | MERCK PATENT GmbH (DE) | 1983-11-16 | — | — | EP | disclosed |
| EP-0072926-A1 | 2-Arylimidazopyridines | MERCK PATENT GmbH (DE) | 1983-03-02 | — | — | EP | disclosed |
| US-4151291-A | ANALGESICS | UNICLER (FR) | 1979-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11129909-B2 | Conjugate and block copolymer containing fluorescent chromophore and preparation method therefor and use thereof | WEE1, FAR1, FURIN | TYR 1768/4885TRIM24 4068/4885TRIM33 3269/4885 |
| US-20200155707-A1 | CONJUGATE AND BLOCK COPOLYMER CONTAINING FLUORESCENT CHROMOPHORE AND PREPARATION METHOD THEREFOR AND USE THEREOF | WEE1, FAR1, FURIN | TYR 1768/4885TRIM24 4068/4885TRIM33 3269/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.